Funds holding RAPT THERAPEUTICS INC
ISIN US75382E2081 · United States · LEI 549300MB473BIU78ES48
- Fund holders
- 15
- Of which ETFs
- 6 9 other funds
- Value held
- 60.3M $
- Share of capital
- 3.8 % of 27.7M shares on Nov 3, 2025
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| BlackRock Event Driven Equity Fund BlackRock Large Cap Series Funds, Inc. | 620,512 | 36M $ | 0.73 % | 2.24 % | as of Feb 27, 2026 ↗ |
| THE ARBITRAGE FUND ARBITRAGE FUNDS | 100,700 | 5.8M $ | 0.72 % | 0.36 % | as of Feb 28, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 99,769 | 5.8M $ | 0.01 % | 0.36 % | as of Feb 28, 2026 ↗ |
| Invesco Dorsey Wright SmallCap Momentum ETF Invesco Exchange-Traded Fund Trust II | 58,443 | 3.4M $ | 0.88 % | 0.21 % | as of Feb 28, 2026 ↗ |
| AltShares Merger Arbitrage ETF AltShares Trust | 39,720 | 2.3M $ | 2.23 % | 0.14 % | as of Feb 28, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 35,839 | 2.1M $ | 0.00 % | 0.13 % | as of Feb 28, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 27,877 | 1.6M $ | 0.00 % | 0.10 % | as of Feb 28, 2026 ↗ |
| AB All Market Total Return Portfolio AB PORTFOLIOS | 16,896 | 979.6K $ | 0.23 % | 0.06 % | as of Feb 28, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 16,552 | 959.7K $ | 0.00 % | 0.06 % | as of Feb 28, 2026 ↗ |
| Fidelity Nasdaq Composite Index ETF Fidelity Commonwealth Trust | 9,858 | 571.6K $ | 0.01 % | 0.04 % | as of Feb 28, 2026 ↗ |
| ProShares Merger ETF ProShares Trust | 6,329 | 367K $ | 2.34 % | 0.02 % | as of Feb 28, 2026 ↗ |
| AltShares Event-Driven ETF AltShares Trust | 5,056 | 293.1K $ | 2.74 % | 0.02 % | as of Feb 28, 2026 ↗ |
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 1,551 | 89.9K $ | 0.12 % | 0.01 % | as of Feb 28, 2026 ↗ |
| ProShares Ultra Nasdaq Biotechnology ProShares Trust | 1,279 | 74.2K $ | 0.08 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Water Island Event-Driven Fund ARBITRAGE FUNDS | 100 | 5.8K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| AltShares Event-Driven ETF AltShares Trust | 2.74 % | as of Feb 28, 2026 ↗ |
| ProShares Merger ETF ProShares Trust | 2.34 % | as of Feb 28, 2026 ↗ |
| AltShares Merger Arbitrage ETF AltShares Trust | 2.23 % | as of Feb 28, 2026 ↗ |
| Invesco Dorsey Wright SmallCap Momentum ETF Invesco Exchange-Traded Fund Trust II | 0.88 % | as of Feb 28, 2026 ↗ |
| BlackRock Event Driven Equity Fund BlackRock Large Cap Series Funds, Inc. | 0.73 % | as of Feb 27, 2026 ↗ |
| THE ARBITRAGE FUND ARBITRAGE FUNDS | 0.72 % | as of Feb 28, 2026 ↗ |
| AB All Market Total Return Portfolio AB PORTFOLIOS | 0.23 % | as of Feb 28, 2026 ↗ |
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 0.12 % | as of Feb 28, 2026 ↗ |
| ProShares Ultra Nasdaq Biotechnology ProShares Trust | 0.08 % | as of Feb 28, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 0.01 % | as of Feb 28, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 15 | -27 | 1,040,481 | -59.3 % |
| 2026Q1 | 42 | +14 | 2,556,177 | +220.6 % |
| 2025Q4 | 28 | +5 | 797,382 | -14.4 % |
| 2025Q3 | 23 | 931,247 |
Declared shareholders of RAPT THERAPEUTICS INC
There is 1 beneficial ownership filing. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| RTW Investments, LP and 1 other | 0.00 % | 0 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Funds holding RAPT THERAPEUTICS INC". https://titelia.com/en/stocks/rapt-therapeutics-inc-US75382E2081